Search
Arvinas Inc
ARVNAdd to Watchlist
8.390USD
+0.190+2.32%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
541.15MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
8.50%
Vanguard Portfolio Management, LLC
6.03%
D. E. Shaw & Co., L.P.
5.72%
Pfizer Inc
5.36%
Vanguard Capital Management, LLC
4.17%
Other
70.23%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
8.50%
Vanguard Portfolio Management, LLC
6.03%
D. E. Shaw & Co., L.P.
5.72%
Pfizer Inc
5.36%
Vanguard Capital Management, LLC
4.17%
Other
70.23%
Shareholder Types
Shareholders
Proportion
Investment Advisor
36.20%
Hedge Fund
25.48%
Investment Advisor/Hedge Fund
20.19%
Corporation
5.36%
Research Firm
2.56%
Venture Capital
2.50%
Individual Investor
2.47%
Pension Fund
0.55%
Bank and Trust
0.34%
Other
4.35%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
522
53.93M
83.59%
-45.35M
2025Q4
513
61.93M
168.36%
-2.99M
2025Q3
525
64.92M
150.53%
-4.18M
2025Q2
518
67.55M
122.76%
+4.71M
2025Q1
504
63.19M
117.99%
-22.92M
2024Q4
484
75.18M
115.79%
+228.04K
2024Q3
476
75.20M
114.63%
+1.35M
2024Q2
469
73.21M
109.58%
+2.16M
2024Q1
476
70.86M
103.71%
+13.21K
2023Q4
483
66.87M
80.36%
+15.93M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
5.48M
8.57%
+310.94K
+6.01%
Dec 31, 2025
D. E. Shaw & Co., L.P.
3.69M
5.77%
+284.18K
+8.35%
Dec 31, 2025
Pfizer Inc
3.46M
5.41%
--
--
Dec 31, 2025
TCG Crossover Management, LLC
2.67M
4.17%
+1.05M
+64.85%
Dec 31, 2025
Point72 Asset Management, L.P.
2.32M
3.62%
+2.32M
--
Dec 31, 2025
State Street Investment Management (US)
1.84M
2.88%
-29.68K
-1.58%
Dec 31, 2025
Armistice Capital LLC
1.80M
2.81%
+600.00K
+50.00%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.62M
2.54%
-46.69K
-2.80%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.76%
State Street SPDR S&P Pharmaceuticals ETF
1.65%
Virtus LifeSci Biotech Clinical Trials ETF
0.91%
Invesco NASDAQ Future Gen 200 ETF
0.7%
iShares U.S. Pharmaceuticals ETF
0.28%
Federated Hermes MDT Small Cap Core ETF
0.24%
Zacks Small/Mid Cap ETF
0.22%
iShares Health Innovation Active ETF
0.16%
ProShares Ultra Nasdaq Biotechnology
0.11%
Invesco RAFI US 1500 Small-Mid ETF
0.1%
View more
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion1.76%
State Street SPDR S&P Pharmaceuticals ETF
Proportion1.65%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.91%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.7%
iShares U.S. Pharmaceuticals ETF
Proportion0.28%
Federated Hermes MDT Small Cap Core ETF
Proportion0.24%
Zacks Small/Mid Cap ETF
Proportion0.22%
iShares Health Innovation Active ETF
Proportion0.16%
ProShares Ultra Nasdaq Biotechnology
Proportion0.11%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.1%